The results showed that the xenografts carrying control shRNA GSCs exhibited more rapid tumor formation, while, in stark contrast, tumor growth was significantly repressed in the xenografts carrying GSCs with USP21 depletion (Fig. 4f). The gene discussed is USP21; the disease is neoplasm.